medigraphic.com
Patología Revista Latinoamericana

2011, Number 2

<< Back Next >>

Patol Rev Latinoam 2011; 49 (2)

Cardiac tamponade secondary to metastasis of gastric adenocarcinoma in pericardial

Cisneros VSA, García AJ, Castellanos G

Language: Spanish
References: 19
Page: 145-150
PDF size: 501.32 Kb.


ABSTRACT

We present the case of an adult woman with cardiac tamponade and death associated to pericardial metastasis from a diffuse gastric adenocarcinoma that lacked gastrointestinal clinical manifestations. These diagnoses were not established until post-mortem pathological examination. The clinical differential diagnoses with an autoimmune disease as well as pitfalls in the cytological diagnosis dealing with pericardial effusion material are discussed. Cardiac tamponade due to pericardial metastases from gastrointestinal cancers are exceptional events hardly ever diagnosed in clinical practice.


REFERENCES

  1. Domínguez AB, Linares P, Vivas S, Castañón C, et al. Cardiac tamponade as the first manifestation of gastric cancer recurrence. Gastroenterol Hepatol 2002;25:577.

  2. Kobayashi M, Okabayashi T, Okamoto K, Namikawa T, Araki K. Clinicopathological study of cardiac tamponade due to pericardial metastasis originating from gastric cancer. World J Gastroenterol 2005;11(44):6899-6904.

  3. Adenle AD, Edwards JE. Clinical and patologic features of metastatic neoplasms of the pericardium. Chest 1982;81:166-169.

  4. Escobar A, Beltrán R, Buitrago R. Taponamiento cardiaco en pacientes con neoplasia primaria conocida. Revista CES Medicina 2002;16(1):35-38.

  5. Miyanari N, Iyama K, Baba H. A patient with 43 synchronous early gastric carcinomas with a Krukenberg tumor and pericardial metastasis. Gastric Cancer 2007;10(2):135-139.

  6. Gray W, Kocjan G. Diagnostic cytopathology. 2nd ed. London: Elsevier; 2003:103-244.

  7. Wilkes JD, Fidias P, Vaickus L, Perez RR. Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute. Cancer 1995;15(76):1377-1387.

  8. Kusaba H, Fujihara M. Systemic chemotherapy of TS-1 and cisplatin for gastric signet-ring cell carcinoma presenting as cardiac tamponade. Med Oncol 2008;25(2):241-244.

  9. Jacobs I, Bast RC Jr. The CA125 tumour-associated antigen: a review of the literature. Hum Reprod 1989;4(1):1-12.

  10. Tochi A, Costa G, Lepre L. The role of serum and gastric juice leves of carcinoembrionic antigen, CA19-9 and CA72.4 in patients with gastric cancer. J Cancer Res Clin Oncol 1998;124:450-455.

  11. Adams BB, Mutasim DF. The diagnostic value of anti-nuclear antibody testing. Int J Dermatol 2000;39:887-891.

  12. Sakai Y, Minouchi K, Ohta H, Annen Y, Sugimoto T. Cardiac tamponade originating from primary gastric signet ring cell carcinoma. J Gastroenterol 1999;34(2):250-252.

  13. Funk L, Hartmann D, Apel D, Spiethoff A, et al. Symptomatic pericardial effusion as initial manifestation of gastric signet ring cell carcinoma. Dtsch Med Wochenschr 2003;128(16):870-873.

  14. Kohnoe S, Maehara Y, Takahashi I, Saito A, et al. Intrapericardial mitomycin C for the management of malignant pericardial effusion secondary to gastric cancer: case report and review. Chemotherapy 1994;40(1):57-60.

  15. Taylor-Papadimitriou J, Finn OJ. Biology, biochemistry and immunology of carcinoma-associated mucins. Immunol Today 1997;18(3):105-107.




2020     |     www.medigraphic.com